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A novel sensitive binding assay for quantitation ofa low-molecular-weight phosphomannosyl 
receptor (41-46 K) was devised. The receptor was immobilized by immunochemical means in 
the wells of polystyrene multiwell plates. The lysosomal enzyme ligand, testicular o-galactosi- 
dase. ‘was added and receptor-bound B-galactosidase was measured by conventional colorimet- 
tic analysis using p-nitrophenyl &galactoside as substrate. Inhibitors of the binding of 8-galac- 
tosidase to the receptor were removed prior to addition of fi-galactosidase and did not interfere 
with the assay. Low-molecular-weight phosphomannosyl receptor was readily quantitated in 
the range of 4 to 100 ng of receptor protein. Binding of 8-galactosidase to the receptor was 
specifically inhibited by 5 ITIM mannose 6-phosphate. The receptor exhibited optimum binding 
of fl-galactosidase at pH 5.7 and was saturated with fi-galactosidase at 310 munits/ml in the 
presence of 20 tIIM MnC&. The requirement for MnClz was greatly diminished at higher 
concentrations of fi-galactosidase. Application of the assay procedure to the quantitation of the 
low-molecular-weight phosphomannosyl receptor in mammalian tissues is discussed. E’ 1987 
Academtc Press, Inc. 
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Uptake of extracellular lysosomal en- 
zymes and intracellular transport of newly 
synthesized enzymes by mammalian cells is 
mediated by phosphomannosyl receptors 
( 1). Two species of membrane-associated re- 
ceptors which recognize mannose 6-phos- 
phate residues have been reported. High-mo- 
lecular-weight phosphomannosyl receptor 
(PMR-lT2 IV, approximately 215,000 by 
SDS-PAGE) was originally isolated from 
bovine liver (2) but has since been isolated 
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* Abbreviations used: PMR- 1, high-molecular-weight 
phosphomannosyl receptor: SDS-PAGE, sodium dode- 
cyl sulfate-polyacrylamide gel electrophoresis; PMR-2, 
low-molecular-weight phosphomannosyl receptor; Mes, 
4-morpholineethanesulfonic acid; RIA, radioimmuno- 
assay; Hepes, 4.-(2-hydroxyethyl) 1 -piperazineethane- 
sulfonic acid; PIIS, phosphate-buffered saline. 
from several mammalian tissues ( 1). Lower 
molecular weight phosphomannosyl recep- 
tors (PMR-2) which exhibit molecular 
weights in the range of 41-46.000 on SDS- 
PAGE, have been isolated from bovine testes 
(3) bovine liver, and a transformed macro- 
phage cell line (4). 
PMR-2 is immunologically distinct from 
PMR- 1 and requires addition of divalent cat- 
ions to bind ligand (3.4). It has been sug- 
gested that PMR-1 and PMR-2 serve as al- 
ternate routes for the targeting of lysosomal 
enzymes (4). 
Studies of the binding characteristics of the 
lower molecular weight PMR-2 have been 
hampered by the lack of a suitable assay for 
its biological activity. The biological proper- 
ties of PMR-2 have been largely inferred 
from the capacity of the receptor to bind af- 
finity matrices that contain immobilized 
proteins and oligosaccharides bearing man- 
nose 6-phosphate residues. These chromato- 
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graphic procedures are tedious and require 
substantial quantities of receptor. Further- 
more, PMR-2 canot be adsorbed onto affin- 
ity columns from crude extracts that contain 
high concentrations of binding inhibitors 
unless the extracts are greatly diluted (3). 
We now report a novel binding assay for 
PMR-2 based on the immunochemical im- 
mobilization of receptor in the wells of poly- 
styrene multiwell plates. The assay proce- 
dure takes advantage of the propensity of 
immobilized receptor to bind lysosomal /3- 
galactosidase. Using this procedure, the 
characteristics of the binding of lysosomal 
enzyme to the receptor can be determined. 
The methodology may be useful for the de- 
termination of other receptors that readily 
dissociate ligand since only a very short time 
is required to wash the receptor-ligand com- 
plex. 
MATERIALS AND METHODS 
Phosphomannosyl receptors, PMR- 1 and 
PMR-2, were extracted and purified by af- 
finity chromatography on phosphopenta- 
mannose-substituted aminoethyl agarose as 
previously described (2,3). Traces of PMR-I 
were removed from PMR-2 preparations by 
an additional cycle of affinity chromatogra- 
phy. Affinity-purified bovine testicular /3-ga- 
lactosidase was prepared by the procedure of 
Distler and Jourdian (5). A “high-binding” 
fraction of P-galactosidase (enriched in en- 
zyme species containing elevated levels of 
covalently-bound mannose 6-phosphate) 
was obtained by chromatography on DEAE- 
Sephacel(6). 
Rabbit antisera to PMR-1 (2) and PMR-2 
(3) were prepared as described. Constituents 
of anti-PMR-2 that reacted with PMR-I 
were removed by adsorption on a column 
containing affinity-immobilized PMR- 1. 
PMR-1 (0.5 mg) contained in 1 ml of bind- 
ing solution (0.5 M NaCl. 0.1% Triton 
X-100, 0.02% NaN,, and 0.05 M sodium 
Mes buffer, pH 6.0) was applied to a 1 
x Z-cm column of phosphopentamannose- 
substituted aminoethyl agarose. The column 
was washed with 50 ml of the binding solu- 
tion described above without Triton X-100. 
Anti-PMR-2 antiserum (10 ml) was applied 
to the column at 4°C and the column was 
washed with 10 ml of binding solution lack- 
ing Triton X-100. The twofold diluted anti- 
serum did not react with PMR-1 as deter- 
mined by RIA (7) and a binding assay (3) but 
retained full activity against PMR-2 in the 
multiwell assay procedure described below. 
Analyses were performed in multiwell 
Nunc-Immuno Plates I, Intermed Nunc, 
Denmark. Organic buffers, Hepes and Mes, 
and affinity-isolated antibody to rabbit IgG 
(whole molecule, developed in goat) were 
obtained from Sigma Chemical Co. 
Protein content was measured by the pro- 
cedure of Peterson (8). 
Step 1: Preparation qf’ untihoc/~~ c.out~~I 
\~ells. Wells were coated with a solid-phase 
second antibody affinity-purified anti-rabbit 
IgG, to spare the primary antiserum (9). 
Stock solutions of the second antibody were 
stored at -20°C in physiological saline at a 
concentration of 1 mg/ml. One day before 
assay, stock solutions of the second antibody 
were diluted to 2.5 pug protein/ml with PBS, 
pH 8.5, and each well was filled with the 
diluted solution. The plate was covered and 
left at room temperature overnight. Excess 
antibody was removed by aspiration and the 
wells were washed twice with solution A ( 1% 
BSA. 0.05% Tween 20, 0.02% NaN3, 0.15 M 
NaCl, and 0.05 M sodium Hepes, pH 7.2j. 
The primary antiserum, rabbit anti-PMR-2, 
was diluted 1:400 from the original serum 
with solution A, and 200 ~1 was added to 
each well. The plate was covered and incu- 
bated at room temperature on a platform 
rocker (Adams, Nutator) for 2 h. The wells 
were aspirated and rinsed two times with so- 
lution A, and receptor preparations were 
added as described below. 
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Diluted primary antiserum could be stored 
at 4°C for at least 1 week. Diluted antiserum 
could be reused at least five times without 
significant loss of receptor-binding capacity. 
Stq I: Iinmohilixtion of‘ rrwptor. Solu- 
tions of purified PMR-2, or extracts of tis- 
sues to be analyzed, were diluted with solu- 
tion A to a concentration of 20-200 ng re- 
ceptor protein/ml and 200~~1 aliquots of the 
appropriate dilutions were added to the 
wells. Reagent blanks lacking receptor were 
also prepared, 
When crude tissue extracts were analyzed, 
controls were included to correct for nonspe- 
cific binding of /3-galactosidase. In these con- 
trols equivalent amounts of crude extract 
were added to the wells and mannose 6- 
phosphate was added during subsequent ap- 
plication of @galactosidase. 
The receptor solutions were allowed to in- 
cubate on the rocker platform for 2 h and the 
wells were again rinsed two times with solu- 
tion A prior to addition of ligand. 
Step 3: Addition ofligand. Stock solutions 
of high-binding bovine testicular P-galactosi- 
dase (6-8 units/ml) were diluted to 400 
munits/ml with solution B (5% BSA. 0.05% 
Tween 20. 0.02% NaN,. 0.15 M NaCl. 0.02 
M MnCl?, and 0.05 M sodium Mes buffer, 
pH 5.7) and 100~~1 aliquots were placed in 
each well. Twenty-five microliters of 25 mM 
mannose 6-phosphate in solution B was 
added to the control wells described above 
and 25 ~1 of solution B was added to the 
remaining wrlls. Inorganic phosphate was 
excluded from the fl-galactosidase since for- 
mation of insoluble manganese phosphate 
resulted in nonspecific retention of &galac- 
tosidase in the wells. Phosphate was removed 
from @galactosidase preparations, if neces- 
sary, by dialysis against 100 vol of 0.05 M 
sodium Mes., pH 5.7, containing 0.02% 
NaN3. Following incubation of the plate on 
the rocker platform at room temperature for 
2 h, excess &-galactosidase was removed by 
alternately (four times) flicking the solution 
from the wells and flooding the plate with a 
solution consisting of 0.02 M MnQ, 0.15 M 
NaCl, 0.02% NaN,, and 0.05 M sodium ace- 
tate, pH 5.7. The final washing procedure 
was completed within 2 min to minimize dis- 
sociation of ligand from the immobilized re- 
ceptor. 
Step 4: .Ls.sa!3 qf P-~~ulac’to.sida.scJ. A sub- 
strate mixture (200 ~1) consisting of 0.19% 
BSA, 0.15 M NaCl, 0.02% NaN,, 0.0 1 M p- 
nitrophenyl-P-galactopyranoside. and 0.05 M 
sodium acetate (pH 4.3) was added to each 
well. The plates were covered and placed at 
37°C for 15-20 h. The reaction was stopped 
by addition of 100 ~1 of 0.5 M glycine- 
NaOH, pH 10. The contents of the wells 
were mixed and the absorbance was deter- 
mined at 400 nm in a multiwell plate reader 
or, alternatively, aliquots were removed 
from each well and the absorbance was de- 
termined in a spectrophotometer. One unit 
of /S-galactosidase was defined as that 
amount which produced I pmol p-nitro- 
phenol/min. 
RESULTS AND DISCUSSION 
Immobilization of PMR-2 in the wells of 
multiwell plates was accomplished by combi- 
nation of direct binding of the receptor to the 
surface of the polystyrene wells and by use of 
an immunochemical linking system that in- 
creased the amount of bound receptor ap- 
proximately IO-fold. The immunochemical 
linking system was composed of a primary 
antiserum that binds PMR-2 and an affinity- 
purified anti-rabbit IgG antibody (second 
antibody) that maximized immobilization of 
the immunoglobulins contained in the pri- 
mary antiserum. 
Antisera to PMR-2 exhibited cross-reac- 
tivity with PMR-1 (3). While the cross-reac- 
tivity did not affect the immobilization of 
purified PMR-2, it prevented specific immo- 
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bilization of PMR-2 from solutions contain- 
ing both PMR-1 and PMR-2. Antibody 
against PMR-1 was removed from the pri- 
mary antiserum by passage through a col- 
umn of affinity-immobilized PMR-1 as de- 
scribed under Materials and Methods. The 
adsorbed antiserum was suitable for estima- 
tion of PMR-2 in mixtures containing each 
receptor (see Estimation of PMR-2 in tissue 
extracts below). 
ally, use of the antibodies conferred specific- 
ity on the type of phosphomannosyl receptor 
that was immobilized. 
Use ofSecond .4ntihody 
PMR-2 could be adsorbed to the surface of 
the polystyrene wells in the absence of the 
immunochemical linking system. The 
amount of PMR-2 bound in this fashion ap- 
proximated 10% of the total receptor added 
to each well (Fig. 1). The amount of nonim- 
munochemically bound PMR-2 increased 
with the time the receptor was left in the 
wells and reached a maximum after 3-5 
days. At 5 days the response was of the same 
magnitude as that obtained in 2 h using the 
immunochemical linking system. Immuno- 
chemical linking was, therefore, not essential 
for immobilization of PMR-2 but its use re- 
duced the time required to immobilize the 
receptor from several days to 2 h. Addition- 
Pretreatment of the wells with affinity-pu- 
rified anti-rabbit IgG allowed the use of 
lower amounts of primary antiserum. For 
example, when the wells were not treated 
with the second antibody, 10 times more 
primary antiserum was required to immobi- 
lize an equivalent amount of PMR-2. The 
optimal amount of second antibody was es- 
tablished by empirical means. When a lo- 
fold higher concentration of second antibody 
was applied to the wells, the amount of 
PMR-2 that was bound was reduced nearly 
50%. Presumably, excessive second antibody 
leads to inactivation of primary immuno- 
globulins (9). 
Binding of P-Galactosidase to 
Immobilized PMR-2 
PMR-2 (ng) 
FIG. 1. Effect of PMR-2 concentration on the reten- 
tion of P-galactosidase in the multiwell binding assay: 
(0) complete assay system; (A) wells not treated with 
primary antiserum in Step 1: (m), 5 mM mannose 6- 
phosphate present during incubation with B-galactosi- 
dase in Step 3. 
The conditions for the optimal binding of 
the enzyme ligand to the receptor could be 
readily determined by modification of the 
binding medium. Binding of ligand to low- 
molecular-weight forms of phosphomanno- 
syl receptor has been suggested to require a 
divalent cation (3.4). As shown in Fig. 2, the 
presence of MnC12 in the medium increased 
the amount of P-galactosidase bound to 
PMR-2 by 50%. The extent of enhancement 
of ligand binding by MnCl* was affected by 
the concentration of P-galactosidase as 
shown in Fig. 3. At concentrations of P-ga- 
lactosidase above 500 munits/ml, enhance- 
ment of binding by MnCl, was less than 5%. 
These results suggest that Mn2+ increases the 
association constant for the receptor-ligand 
complex. MnC12 (20 mM) was used routinely 
during ligand binding in the multiwell assay 
since it permitted the use of a lower optimal 
concentration of P-galactosidase. MnC12 was 
not required for the attachment of antibodies 
or immobilization of PMR-2 in the wells. In 
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MnCl2 CONCENTRATION (mM) 
FIG. 2. Effect of MnCI, concentration on the binding 
of fl-galactosidaje to PMR-2. The multiwell binding 
assay was performed as described under Materials and 
Methods except /%galactosidase was reduced to 150 
munits/ml in Slep 3 to enhance the effect of MnClz 
concentration (see Fig. 3). 
a similar multiwell binding assay performed 
with PMR-1 and anti-PMR-1 primary anti- 
serum, MnC’l* did not significantly affect 
binding of /3-galactosidase to PMR- 1 (results 
not shown). 
The optimum pH for binding of P-galac- 
tosidase to PMR-2 was determined by alter- 
- Go- I 
0 50 300 450 600 
p-GALACTOSIDASE CONCENTRATION (mun!ts/mll 
_J 
45 5 55 6 65 7 7.5 
PH 
FIG. 3. Effect of fl-galactosidase concentration on the FIG. 4. Effect of pH on the binding of $-galactosidase 
binding of &galactosidase to PMR-2. The multiwell to PMR-2. The multiwell binding assay was performed 
binding assay was performed as described under Mate- as described under Materials and Methods except the 
rials and Methods except that the indicated levels of buffers in the binding medium in Step 3 were (A) 0.05 M 
@-galactosidase were used in Step 3 (0) in the presence of sodium acetate, (0) 0.05 M sodium Mes, and (m) 0.05 hr 
ing the pH of the binding medium (Fig. 4). A 
pH of 5.7 was selected for estimations of 
PMR-2: this pH value also proved to be op- 
timal for the assay of PMR-I (results not 
shown). 
Determination of PMR-2 
PMR-2 can be estimated by the multiwell 
binding assay in the range of 4- 100 ng re- 
ceptor protein/well (Fig. 1). Above this range 
the response to PMR-2 was reduced, pre- 
sumably because bound antibody became 
limiting. Attempts to increase the capacity of 
the wells to bind PMR-2 by increasing time 
of incubation and by addition of larger 
amounts of primary antisera were unreward- 
ing. Maximum immunochemical reaction 
was achieved in 2 h and even a IO-fold in- 
crease in primary antiserum resulted in 
< 10% increase in the level of PMR-2 bound. 
Control wells that contained 5 mM man- 
nose 6-phosphate did not retain measurable 
levels of @-galactosidase when purified 
PMR-2 was being measured (Fig. 1). How- 
ever, when crude tissue extracts were exam- 
20 mM MnClz and (m) in the absence of added MnC&. sodium Hepes at the indicated pH. 
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ined, nonspecific binding of @-galactosidase 
occurred (see Estimation of PMR-2 in crude 
tissue extracts). In these instances values ob- 
tained in the presence of mannose 6-phos- 
phate were subtracted from those obtained in 
the absence of mannose 6-phosphate. 
Tissue Extracts 
llse of the multiwell assay procedure to 
estimate PMR-2 in crude tissue extracts is 
complicated by two factors. First, both 
PMR- 1 and PMR-2 receptors bind to a small 
extent directly to the polystyrene surface of 
the wells. Therefore, when mixtures of 
PMR-I and PMR-2 are examined by the 
multiwell procedure, a small amount of /3- 
galactosidase may be retained in the plate 
bound to PMR- 1. This direct, nonimmuno- 
chemical binding of receptor approximates 
10% of the content of either receptor applied 
to the wells and is not reduced by inclusion 
of up to 5% bovine serum albumin in the 
receptor-immobilization medium. Interfer- 
ence by PMR-1 is somewhat reduced be- 
cause PMR- 1 binds only 17% of the P-galac- 
tosidase bound by an equivalent amount of 
AND JOURDIAN 
PMR-2 (based on protein content, results 
not shown). 
A second problem with assay of PMR-2 in 
crude extracts results from nonspecific bind- 
ing of fl-galactosidase in the wells (retention 
of P-galactosidase in the presence of 5 mM 
mannose 6-phosphate). This occurs when 
serum or crude Triton X- 100 extracts of tis- 
sues have been applied to the wells (Table 1). 
Frequently a visible film may be seen on the 
surface of the wells and &galactosidase ad- 
heres to the residue. The substances responsi- 
ble for this nonspecific binding of P-galacto- 
sidase have not been identified. 
For the reasons described above, crude tis- 
sue extracts tend to yield multiwell values for 
PMR-2 that are higher than those obtained 
by RIA. However, the multiwell procedure 
has proved accurate and convenient for 
monitoring PMR-2 fractions following ini- 
tial purification steps. The procedure is of 
particular value for large numbers of samples 
containing low levels of PMR-2 and for assay 
of PMR-2 when the biological activity must 
be determined. In addition, the multiwell 
assay procedure has been modified in this 
laboratory to screen polyclonal and mono- 
TABLE 1 
EFFECTO~ RWEPTOR PREPARAUONON/K?ALACTOSIDASE IMMOBILIZATION 
&Galactosidase bound (~units/well) 
Receptor Treatment Without Man-6-P With Man-6-P 
PMR-2 (50 ng) 
PMR-2 (50 ng) 
PMR-1 (250 ng) 
PMR-1 (250 ng) 
Fetal calf serum (50 ~1)” 













Note. Solutions were assayed for PMR-2 by multiwell plate assay procedure. The indicated amounts ofthe receptor 
preparations were added as described in Step 2 under Materials and Methods. Each value was obtained by averaging 
the results from five wells. Nonspecifically bound /%gaLactosidase was measured by inclusion of 5 mM mannose 
6-phosphate in Step 3. 
il Bovine fetal calf serum contained 2 1.5 pg PMR-1 and ~0.1 Kg PMR-2/ml by RIA procedures (2.3). 
h Bovine testes cell membrane acetone powder (5 g) was extracted with 300 ml of a solution containing 1% Triton 
X-100 (3). The extract contained 7.7 pg PMR-1 and 3.3 wg PMR-2/ml by RIA procedures (2.3). 
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clonal antibo’dy fractions. In this case the ap- 
propriate species-directed anti-IgG second 
antibody is employed along with the primary 
anti-PMR-2 immunoglobulins from ascites 
fluids. or serum samples. 
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